Live Breaking News & Updates on Apellis pharmaceuticals

Stay informed with the latest breaking news from Apellis pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Apellis pharmaceuticals and stay connected to the pulse of your community

Xponance Inc. Sells 939 Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Xponance Inc. reduced its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,927 shares of the company’s stock after selling 939 shares during the quarter. Xponance Inc.’s holdings in Apellis Pharmaceuticals […]

China , Timothy-eugene-sullivan , Pascal-deschatelets , Robertw-baird , Covestor-ltd , Quarter-for-apellis-pharmaceuticals , Stephens-consulting , Advisors-inc , Nasdaq , News-ratings-for-apellis-pharmaceuticals-daily , Apellis-pharmaceuticals , Apellis-pharmaceuticals-stock-performance

Stock Analysts' Updated EPS Estimates for April 25th (APLS, BITF, LII, LSTA, MOH, NOW, NPI, NTB, STC, UHS)

Stock Analysts' Updated EPS Estimates for April 25th (APLS, BITF, LII, LSTA, MOH, NOW, NPI, NTB, STC, UHS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William-blair , Raymond-james , News-ratings-for-apellis-pharmaceuticals-inc-daily , Apellis-pharmaceuticals , Apellis-pharmaceuticals-inc , Stewart-information-services , Lennox-international , Needham-company , Health-services , Stock-analyst , Information-services , Apellis-pharmaceuticals-inc-daily

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Netherlands , Malvern , Worcestershire , United-kingdom , United-states , Cambridge , Cambridgeshire , Harvard-university , Massachusetts , Boston , California

First-Ever Combined Heart Pump and Pig Kidney Transplant from NYU Langone Gives New Hope to Patient with Terminal Illness

First-Ever Combined Heart Pump and Pig Kidney Transplant from NYU Langone Gives New Hope to Patient with Terminal Illness
longisland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from longisland.com Daily Mail and Mail on Sunday newspapers.

Columbia-center , New-york , United-states , New-jersey , Paris , France-general- , France , Sapnaa-mehta , Imad-aljabban , Rebecca-esker , Bonniee-lonze , David-sachs

DelveInsight Business Research, LLP: Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034

DelveInsight Business Research, LLP: Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Spain , France , Germany , United-states , Italy , Japan , United-kingdom , Annexon-biosciences , Belite-bio , Iveric-bio , Prnewswire-delveinsight , Gensight-biologics

Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034

/PRNewswire/ -- DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding of current treatment practices, Stargardt...

United-states , Japan , Germany , United-kingdom , Spain , France , Italy , Shruti-thakur , Prnewswire-delveinsight , Gensight-biologics , Cellcure-neurosciences , Stargardt-diseasetherapies

Analysts Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Target Price at $78.60

Analysts Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Target Price at $78.60
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

A-sinclair-dunlop , Raymond-james , Timothy-eugene-sullivan , Analyst-recommendations-for-apellis-pharmaceuticals , Goldman-sachs-group , First-horizon-advisors-inc , Apellis-pharmaceuticals , News-ratings-for-apellis-pharmaceuticals-daily , Apellis-pharmaceuticals-inc , Financial-wealth-managment , Us-bancorp , Covestor-ltd

Brokerages Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Price Target at $78.60

Brokerages Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Price Target at $78.60
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Cedric-francois , Pascal-deschatelets , Securities-exchange-commission , Profund-advisors , Apellis-pharmaceuticals-inc , News-ratings-for-apellis-pharmaceuticals-daily , Charles-schwab-investment-management-inc , Jefferies-financial-group , Needham-company , Wynnefield-capital-inc

Jennison Associates LLC Lowers Holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Jennison Associates LLC reduced its position in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 7.5% in the fourth quarter, Holdings Channel reports. The firm owned 3,275,922 shares of the company’s stock after selling 266,287 shares during the period. Jennison Associates LLC’s holdings in Apellis Pharmaceuticals were worth $196,097,000 at the end of […]

Pascal-deschatelets , Nur-nicholson , Fiera-capital-corp , Goldman-sachs-group , Jefferies-financial-group , Holdings-channel , Apellis-pharmaceuticals-stock-down , Apellis-pharmaceuticals , Vanguard-group-inc , Quarter-for-apellis-pharmaceuticals , Jpmorgan-chase-co , Charles-schwab-investment-management-inc

Jennison Associates LLC Has $196.10 Million Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Jennison Associates LLC lessened its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 7.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,275,922 shares of the company’s stock after selling 266,287 shares during the period. Jennison Associates LLC owned 2.76% of Apellis Pharmaceuticals […]

United-states , American , Nur-nicholson , Pascal-deschatelets , Raymond-james , Wynnefield-capital-inc , Jefferies-financial-group , Goldman-sachs-group , Apellis-pharmaceuticals , Apellis-pharmaceuticals-stock-down , Quarter-for-apellis-pharmaceuticals , Jpmorgan-chase-co